Objectives: To evaluate dose-related outcome of induction of labor
(IOL) using misoprostol vaginal inserts (MVI) in multipara pregnant
women so as to determine the appropriate dose for getting trial success
defined as having vaginal delivery (VD) within 24-hr induction-todelivery
(ITD) interval.
Patients & Methods: 644 pregnant women underwent clinical
evaluation and vaginal examination to determine Bishop score using
the Simplified Bishop Score (SBS). All women received 25 μg MVI
only once and were monitored for labor progress as judged by SBS and
uterine contractions with fetal heart monitoring. In absence of fetal
distress manifestations and membranes were still intact, but uterine
contractions occurred |
